Rapamycin in ischemic stroke: Old drug, new tricks?
The significant morbidity that accompanies stroke makes it one of the world's most devastating neurological disorders. Currently, proven effective therapies have been limited to thrombolysis and thrombectomy. The window for the administration of these therapies is narrow, hampered by the necess...
Principais autores: | Hadley, G, Beard, D, Couch, Y, Neuhaus, A, Adriaanse, B, De Luca, G, Sutherland, B, Buchan, A |
---|---|
Formato: | Journal article |
Publicado em: |
SAGE Publications
2018
|
Registros relacionados
-
Importance of preclinical research in the development of neuroprotective strategies for ischemic stroke.
por: Neuhaus, A, et al.
Publicado em: (2014) -
The role of the endoplasmic reticulum stress response following cerebral ischemia
por: Hadley, G, et al.
Publicado em: (2017) -
Neuroprotection in stroke: the importance of collaboration and reproducibility.
por: Neuhaus, A, et al.
Publicado em: (2017) -
The effect of rapamycin treatment on cerebral ischemia: A systematic review and meta-analysis of animal model studies
por: Beard, D, et al.
Publicado em: (2018) -
Rapamycin induces an eNOS dependent increase in brain collateral perfusion after acute experimental stroke in rats
por: Beard, DJ, et al.
Publicado em: (2019)